ATE401420T1 - Dna detektion unter verwendung von primern, welche mit nicht-fragmentierter dna hybridisieren - Google Patents

Dna detektion unter verwendung von primern, welche mit nicht-fragmentierter dna hybridisieren

Info

Publication number
ATE401420T1
ATE401420T1 AT02793254T AT02793254T ATE401420T1 AT E401420 T1 ATE401420 T1 AT E401420T1 AT 02793254 T AT02793254 T AT 02793254T AT 02793254 T AT02793254 T AT 02793254T AT E401420 T1 ATE401420 T1 AT E401420T1
Authority
AT
Austria
Prior art keywords
dna
colorectal
occur
fragmented
detection
Prior art date
Application number
AT02793254T
Other languages
English (en)
Inventor
Eleanor Dow
Patrick Deegan
Original Assignee
Tayside Health Board
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tayside Health Board filed Critical Tayside Health Board
Application granted granted Critical
Publication of ATE401420T1 publication Critical patent/ATE401420T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT02793254T 2001-12-24 2002-12-24 Dna detektion unter verwendung von primern, welche mit nicht-fragmentierter dna hybridisieren ATE401420T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0130821.2A GB0130821D0 (en) 2001-12-24 2001-12-24 DNA screening

Publications (1)

Publication Number Publication Date
ATE401420T1 true ATE401420T1 (de) 2008-08-15

Family

ID=9928304

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02793254T ATE401420T1 (de) 2001-12-24 2002-12-24 Dna detektion unter verwendung von primern, welche mit nicht-fragmentierter dna hybridisieren

Country Status (10)

Country Link
US (1) US20050042617A1 (de)
EP (1) EP1456414B1 (de)
JP (1) JP2005514073A (de)
AT (1) ATE401420T1 (de)
AU (1) AU2002358913A1 (de)
DE (1) DE60227697D1 (de)
DK (1) DK1456414T3 (de)
ES (1) ES2310615T3 (de)
GB (1) GB0130821D0 (de)
WO (1) WO2003060156A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2012014694A1 (ja) * 2010-07-26 2013-09-12 オリンパス株式会社 糞便由来核酸の合成方法
CN108064273B (zh) * 2015-01-30 2021-07-23 深圳华大生命科学研究院 结直肠癌相关疾病的生物标志物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2149318A1 (en) * 1992-11-13 1994-05-26 Manuel Perucho Identification of neoplasms by detection of genetic insertions and deletions
US5331973A (en) * 1993-03-15 1994-07-26 Fiedler Paul N Method for obtaining stool samples for gastrointestinal cancer testing
DE19530132C2 (de) * 1995-08-16 1998-07-16 Max Planck Gesellschaft Verfahren zur Reinigung, Stabilisierung oder Isolierung von Nukleinsäuren aus biologischen Materialien
US5773649A (en) * 1996-06-10 1998-06-30 Centre De Recherche De L'hopital Sainte-Justine DNA markers to detect cancer cells expressing a mutator phenotype and method of diagnosis of cancer cells
EP1169479B1 (de) * 1999-04-09 2006-06-28 EXACT Sciences Corporation Verfahren zur detektion von nukleinsäuren, welche auf krebs hinweisen
US20020004206A1 (en) * 1999-04-09 2002-01-10 Berger Barry M. Methods of screening for disease
GB0015777D0 (en) * 2000-06-28 2000-08-16 Tayside University Hospitals N DNA Extraction

Also Published As

Publication number Publication date
WO2003060156A3 (en) 2003-11-06
GB0130821D0 (en) 2002-02-06
EP1456414B1 (de) 2008-07-16
WO2003060156A2 (en) 2003-07-24
DK1456414T3 (da) 2008-11-17
AU2002358913A8 (en) 2003-07-30
DE60227697D1 (de) 2008-08-28
US20050042617A1 (en) 2005-02-24
EP1456414A2 (de) 2004-09-15
ES2310615T3 (es) 2009-01-16
JP2005514073A (ja) 2005-05-19
AU2002358913A1 (en) 2003-07-30

Similar Documents

Publication Publication Date Title
Gorgannezhad et al. Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies
Vallée et al. Efficiency of the Therascreen® RGQ PCR kit for the detection of EGFR mutations in non-small cell lung carcinomas
He et al. IgH gene rearrangements as plasma biomarkers in Non-Hodgkin's lymphoma patients
Germano et al. Parallel evaluation of circulating tumor DNA and circulating tumor cells in metastatic colorectal cancer
WO2020132499A3 (en) Systems and methods for using fragment lengths as a predictor of cancer
CA2248981A1 (en) Detection of extracellular tumor-associated nucleic acid in blood plasma or serum using nucleic acid amplification assays
Zhang et al. Detection of low-abundance KRAS mutations in colorectal cancer using microfluidic capillary electrophoresis-based restriction fragment length polymorphism method with optimized assay conditions
Pinzani et al. BRAFV600E detection in melanoma is highly improved by COLD-PCR
PT1631686E (pt) Detecção de displasia de alto grau em células cervicais
WO2015070773A1 (zh) 一种全基因组dna甲基化的导向测序技术
Huang et al. Non-disruptive mutation in TP53 DNA-binding domain is a beneficial factor of esophageal squamous cell carcinoma
WO2022235718A3 (en) Compositions comprising nullomers and methods of using the same for cancer detection and diagnosis
CN111534574A (zh) 一种增强测序灵敏度的基因富集方法
ATE401420T1 (de) Dna detektion unter verwendung von primern, welche mit nicht-fragmentierter dna hybridisieren
DE60332468D1 (de) Analytnachweis
Riahi et al. High-resolution melting (HRM) assay for the detection of recurrent BRCA1/BRCA2 germline mutations in Tunisian breast/ovarian cancer families
Laosinchai-Wolf et al. Sensitive multiplex detection of KRAS codons 12 and 13 mutations in paraffin-embedded tissue specimens
Uhara et al. Simple polymerase chain reaction for the detection of mutations and deletions in the epidermal growth factor receptor gene: applications of this method for the diagnosis of non-small-cell lung cancer
DE69725297D1 (de) Immuno-magnetische zelltrennung zur erkennung von krebsmetastasenbildung-assozierten genen
Rodríguez-Carrascal et al. Evaluation of SNaPshot and Sanger sequencing for the detection of KRAS and NRAS mutations in a sample of Venezuelan patients with colorectal cancer
CN105463087A (zh) 一种braf v600e基因的检测引物组、其构成的反应体系及应用
CN108875314B (zh) 一种基于表观遗传学修饰差异的靶基因的检测方法
Gleissner et al. Comparison of ethidium bromide-stained agarose gel electrophoresis and automated fragment analysis for evaluation of IgH gene products
Gaber et al. Mini review: immunohistochemistry using EGFR-mutant specific antibodies in non-small cell lung carcinoma: accuracy and reliability
Verdu et al. EGFR mutations in lung cancer: a morphological, immunohistochemical and molecular study of lung adenocarcinoma

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1456414

Country of ref document: EP

REN Ceased due to non-payment of the annual fee